About
Research Library
Company Pages
Allergy Therapeutics
Futura Medical
HUTCHMED (Hutchison China MediTech)
MaxCyte
Mereo BioPharma
Nexstim
Redx Pharma
Scancell
Contact
More Company News
Mereo BioPharma
Pricing of $100m Public Offering of ADS
10 Feb 2021
Read More
Mereo BioPharma
Setrusumab partnership with Ultragenyx
17 Dec 2020
Read More
Mereo BioPharma
Update on AIM delisting and agreements with SVB and Kreos Capital
15 Dec 2020
Read More
Mereo BioPharma
Appointment of SVP of Clinical Development
23 Nov 2020
Read More
Mereo BioPharma
Intended cancellation of AIM listing
11 Nov 2020
Read More
Mereo BioPharma
Additions to management team
20 Oct 2020
Read More
Mereo BioPharma
FDA clearance for Phase Ib/II etigilimab anti-TIGIT study
19 Oct 2020
Read More
Mereo BioPharma
Registration statement filed with US SEC
07 Oct 2020
Read More
Mereo BioPharma
Interim H120 results and corporate update
29 Sep 2020
Read More
Mereo BioPharma
Additions and changes to board
28 Sep 2020
Read More
1
2
3
4
5
Return to Mereo BioPharma
© 2019-21 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).
About
Research Library
Company Pages
▼
Allergy Therapeutics
Futura Medical
HUTCHMED (Hutchison China MediTech)
MaxCyte
Mereo BioPharma
Nexstim
Redx Pharma
Scancell
Contact